I think that's kind of why people have a thing against these companies...being able to withstand a 5M loss and still being able to operate is pretty amazing. Pure conjecture on my part, but I would guess that the market is an oligopoly at worst.

quote:
but major changes are hard fought and are won through demonstrated safety profile first, improved efficacy second and competitive pricing/managed care coverage.

I see. This will sound like a rhetorical question, but I don't really mean it as such...then what is the point of taking doctors out for food/drinks if all the important stuff doesn't occur there?

1 ...

Report Post

Posted by the808bass

The Lou

Member since Oct 2012

111525 posts

Posted on 8/24/15 at 9:24 am to Robert Goulet

quote:
I see. This will sound like a rhetorical question, but I don't really mean it as such...then what is the point of taking doctors out for food/drinks if all the important stuff doesn't occur there?

A couple of things. The differences between the drugs in a lot of cases are pretty minor. So, if you're taking an ARB, you're taking an ARB. They could almost put those in the water, the safety profile is so clean. So, if I'm selling an ARB, I need a relationship to differentiate my product. That is the case in dozens of drug classes. Back in the day when antihistamines weren't OTC, there wasn't a huge difference between Zyrtec and Claritin and Allegra was right there too. The intranasal steroids were the same. So when you have very similar drugs, you need a relationship to break through or maintain your business level.

And now, taking doctors out for dinner or drinks doesn't really happen.

As to losing a $5M contract, of course a multibillion company can survive losing a $5M contract. An individual rep can't.

0 ...

Report Post

Posted by Nuts4LSU